Cohort Builder

Create clinically actionable patient cohorts in seconds using the largest cancer testing database in the U.S.

cohort builder stats image

Harness clinically driven, real-world data intuitively visualized with Cohort Builder

Accelerate your biomarker programs, clinical trials and commercial launches with real-time, longitudinal lab data from NeoNucleus, the only cancer testing database covering the complete spectrum of oncology testing modalities for over 1.9 million patients with the highest level of allowable demographic information.

Build patient cohorts in seconds with Cohort Builder’s intuitive drag and drop interface to identify clinically actionable candidates in real-time. Visualize your designed cohorts through a library of packaged reports and dashboards, empowering you to make critical decisions faster and with confidence.

In precision oncology, lab data matters.

Finding patients that match your research and commercial interests is hard. Especially when you are targeting patients with rare diseases or specific biomarkers. Current sources of data, such as EMR and claims data, are incomplete and arrive too late to influence therapeutic decisions.

NeoGenomics Cohort Builder is a first-of-its-kind solution that gives you real-time access to lab data that can indicate biomarker results before a treatment decision is made. And because lab data is longitudinal, you have insight into the entire patient journey, enabling you to build accurate patient cohorts in seconds and visualize the data to make meaningful decisions faster.

Discover the advantage of NeoGenomics lab database – NeoNucleus
The information you want, right when you need it.
Patient RGB alt
1.9M Unique Patients

Our extensive patient database consists of clinical, pathology and lab data spanning the entire patient journey allowing you to build robust cohorts longitudinally. 

unique providers RGB alt color
68K Unique Providers

We act as a collaborative partner to pathologists and oncologists at community practices and hospitals across the U.S.

Growth RGB alt
Over 1.0M Oncology Tests Performed Annually

Our comprehensive testing menu of over 650 tests encompasses all major testing methodologies – Flow Cytometry, FISH, IHC, Cytogenetics, and NGS.

Image analysis RGB alt
Over 1.6M WHOLE-SLIDE Digital Images

 Our robust, multi-modality and heterogenous image bank supports cell classification, expression scoring, spatial analysis and neural network training projects.

cohort builder fact sheet image


Find your patient population of interest from community hospitals and oncology clinics across the US where nearly 80% of oncology patients are treated and biomarker testing disparities are most prevalent.

See Cohort Builder Live

Schedule a demo with a NeoGenomics Data Strategy Consultant to learn how this powerful interface can support and accelerate your biomarker programs, oncology clinical trials and commercial launches.